Holen Sie sich die Stockscreener-App
28.63
0.24%
-0.07
Schlusskurs vom Vortag:
$28.70
Offen:
$28.61
24-Stunden-Volumen:
700.39K
Relative Volume:
1.20
Marktkapitalisierung:
$513.55M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-204.50
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
-17.54%
1M Leistung:
-31.21%
6M Leistung:
+50.84%
1J Leistung:
+78.94%
1-Tages-Spanne:
$27.90
$29.00
1-Wochen-Bereich:
$27.90
$36.05
52-Wochen-Spanne:
$13.57
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Firmenname
Rigel Pharmaceuticals
Sektor
Branche
Telefon
650-624-1100
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RIGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
28.63 | 514.80M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-06-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Eingeleitet | B. Riley Securities | Neutral |
| 2020-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Fortgesetzt | JP Morgan | Overweight |
| 2019-03-01 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Eingeleitet | Citigroup | Buy |
| 2018-05-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-31 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-30 | Bestätigt | Piper Jaffray | Overweight |
| 2016-07-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-04-22 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Bestätigt | Stifel | Buy |
| 2012-11-29 | Eingeleitet | UBS | Neutral |
| 2012-11-06 | Bestätigt | Oppenheimer | Outperform |
| 2012-03-26 | Eingeleitet | Canaccord Genuity | Hold |
| 2010-12-10 | Herabstufung | MP Advisors | Outperform → Market Perform |
Alle ansehen
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
What analysts say about Rigel Pharmaceuticals Inc RI2 stockBollinger Bands Signals & High Profit Market Growth - Early Times
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - sharewise.com
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking Alpha
RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? - simplywall.st
Benign Growth For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Underpins Stock's 26% Plummet - simplywall.st
Strs Ohio Takes Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Voya Investment Management LLC Sells 22,411 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Goldman Sachs Group Inc. Sells 107,461 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 4.9%What's Next? - MarketBeat
Earnings Miss: Is Rigel Pharmaceuticals Inc attractive at current valuationMarket Risk Summary & Fast Entry and Exit Trade Plans - خودرو بانک
Aug Highlights: Can Rigel Pharmaceuticals Inc continue delivering strong returns2025 Market WrapUp & Weekly Stock Breakout Alerts - khodrobank.com
Movement Recap: Can Rigel Pharmaceuticals Inc. continue delivering strong returnsProduct Launch & Real-Time Market Sentiment Alerts - خودرو بانک
Aug Breakouts: Can Rigel Pharmaceuticals Inc continue delivering strong returnsInsider Selling & Short-Term Trading Opportunity Alerts - khodrobank.com
Aug Update: What is the Moat Score of Rigel Pharmaceuticals Inc2025 Market Sentiment & Free Accurate Trade Setup Notifications - خودرو بانک
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - TradingView
Rigel Pharmaceuticals Experiences Valuation Adjustment Amid Strong Financial Metrics and Market Position - Markets Mojo
Acadian Asset Management LLC Buys 188,679 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - MSN
Rigel Pharmaceuticals Sees Valuation Upgrade Amid Strong Financial Performance and Growth - Markets Mojo
Aug Swings: Is Waters Corporation a strong growth stock2025 Sector Review & Fast Moving Trade Plans - خودرو بانک
Dynamic Technology Lab Private Ltd Purchases Shares of 27,117 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals Achieves 172.26% Return, Marking It as a Multibagger in Biotechnology Sector - Markets Mojo
Trading Action: Is Rigel Pharmaceuticals Inc attractive at current valuation2025 Market WrapUp & Weekly Stock Breakout Alerts - خودرو بانک
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $38.20 Consensus Price Target from Analysts - MarketBeat
Jacobs Levy Equity Management Inc. Buys 15,687 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? - MSN
Short Interest in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Declines By 20.7% - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 6.1%Here's Why - MarketBeat
What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - sharewise.com
A Look At The Intrinsic Value Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Yahoo Finance
Is Rigel Pharmaceuticals Inc.’s growth already priced inMarket Risk Summary & Reliable Volume Spike Alerts - beatles.ru
Rafferty Asset Management LLC Purchases Shares of 21,397 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Can Rigel Pharmaceuticals Inc. continue delivering strong returnsQuarterly Profit Review & Free Long-Term Investment Growth Plans - خودرو بانک
Price momentum metrics for Rigel Pharmaceuticals Inc. explained2025 Stock Rankings & Real-Time Volume Triggers - Newser
Can Rigel Pharmaceuticals Inc. lead its sector in growth2025 Investor Takeaways & Long-Term Safe Return Strategies - خودرو بانک
Charles Schwab Investment Management Inc. Has $1.19 Million Stock Holdings in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Do Options Traders Know Something About RIGL Stock We Don't? - sharewise.com
What’s the MACD signal for Rigel Pharmaceuticals Inc.Trade Performance Summary & High Conviction Buy Zone Picks - خودرو بانک
Using data models to predict Rigel Pharmaceuticals Inc. stock movementMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
What earnings revisions data tells us about Rigel Pharmaceuticals Inc.Options Play & Community Consensus Picks - Newser
Will Rigel Pharmaceuticals Inc. bounce back from current supportJuly 2025 Decliners & Target Return Focused Picks - Newser
Technical analysis overview for Rigel Pharmaceuticals Inc. stockJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rigel Pharmaceuticals-Aktie (RIGL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schorno Dean L | EVP & Chief Financial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,734 |
38,020 |
57,235 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 04 '25 |
Sale |
20.92 |
2,125 |
44,457 |
53,500 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,796 |
39,379 |
51,704 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 04 '25 |
Sale |
20.92 |
4,952 |
103,601 |
243,854 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 05 '25 |
Sale |
21.93 |
4,400 |
96,474 |
239,454 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 04 '25 |
Sale |
20.92 |
1,448 |
30,294 |
40,169 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 05 '25 |
Sale |
21.93 |
1,339 |
29,359 |
38,830 |
3.41%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):